BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9877240)

  • 1. Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content.
    Cemazar M; Milacic R; Miklavcic D; Dolzan V; Sersa G
    Anticancer Drugs; 1998 Jul; 9(6):525-30. PubMed ID: 9877240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of combined modality therapy with cisplatin and radiation using electroporation of tumors.
    Sersa G; Kranjc S; Cemazar M
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):1037-41. PubMed ID: 10705027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin.
    Cemazar M; Miklavcic D; Scancar J; Dolzan V; Golouh R; Sersa G
    Br J Cancer; 1999 Mar; 79(9-10):1386-91. PubMed ID: 10188880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients.
    Sersa G; Stabuc B; Cemazar M; Jancar B; Miklavcic D; Rudolf Z
    Eur J Cancer; 1998 Jul; 34(8):1213-8. PubMed ID: 9849482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective treatment of perianal tumors in dogs with electrochemotherapy.
    Tozon N; Kodre V; Sersa G; Cemazar M
    Anticancer Res; 2005; 25(2A):839-45. PubMed ID: 15868917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice.
    Sersa G; Cemazar M; Miklavcic D
    Cancer Res; 1995 Aug; 55(15):3450-5. PubMed ID: 7614485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schedule-dependent interaction between vinblastine and cisplatin in Ehrlich ascites tumors in mice.
    Cemazar M; Auersperg M; Scancar J; Kirbis IS; Pogacnik A; Sersa G
    J Pharmacol Exp Ther; 2002 Jul; 302(1):337-43. PubMed ID: 12065735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model.
    Cemazar M; Miklavcic D; Mir LM; Belehradek J; Bonnay M; Fourcault D; Sersa G
    Eur J Cancer; 2001 Jun; 37(9):1166-72. PubMed ID: 11378348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats.
    Tozon N; Sersa G; Cemazar M
    Anticancer Res; 2001; 21(4A):2483-8. PubMed ID: 11724311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrogene therapy with p53 of murine sarcomas alone or combined with electrochemotherapy using cisplatin.
    Grosel A; Sersa G; Kranjc S; Cemazar M
    DNA Cell Biol; 2006 Dec; 25(12):674-83. PubMed ID: 17233116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients.
    Sersa G; Stabuc B; Cemazar M; Miklavcic D; Rudolf Z
    Clin Cancer Res; 2000 Mar; 6(3):863-7. PubMed ID: 10741708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity.
    Sedlar A; Dolinsek T; Markelc B; Prosen L; Kranjc S; Bosnjak M; Blagus T; Cemazar M; Sersa G
    Radiol Oncol; 2012 Dec; 46(4):302-11. PubMed ID: 23412658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrochemotherapy of mouse sarcoma tumors using electric pulse trains with repetition frequencies of 1 Hz and 5 kHz.
    Sersa G; Kranjc S; Scancar J; Krzan M; Cemazar M
    J Membr Biol; 2010 Jul; 236(1):155-62. PubMed ID: 20607223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases.
    Sersa G; Stabuc B; Cemazar M; Miklavcic D; Rudolf Z
    Melanoma Res; 2000 Aug; 10(4):381-5. PubMed ID: 10985673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin.
    Sersa G; Krzic M; Sentjurc M; Ivanusa T; Beravs K; Kotnik V; Coer A; Swartz HM; Cemazar M
    Br J Cancer; 2002 Oct; 87(9):1047-54. PubMed ID: 12434299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis.
    Mali B; Jarm T; Snoj M; Sersa G; Miklavcic D
    Eur J Surg Oncol; 2013 Jan; 39(1):4-16. PubMed ID: 22980492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrochemotherapy of tumours.
    Sersa G; Miklavcic D
    J Vis Exp; 2008 Dec; (22):. PubMed ID: 19229171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrochemotherapy: a new treatment of solid tumors.
    Mir LM; Morsli N; Garbay JR; Billard V; Robert C; Marty M
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):145-8. PubMed ID: 16767921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor blood flow modifying effect of electrochemotherapy with bleomycin.
    Sersa G; Cemazar M; Miklavcic D; Chaplin DJ
    Anticancer Res; 1999; 19(5B):4017-22. PubMed ID: 10628347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.
    Mizuuchi H; Yoshiga K; Sakurai K; Tsumura M; Takada K
    Anticancer Res; 1996; 16(1):381-7. PubMed ID: 8615640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.